QSAR modeling: where have you been? Where are you going to?; Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research; QSAR without borders; Chalcone derivatives: promising starting points for drug design; QSAR-based virtual screening: advances and applications in drug discovery; Comprehensive characterization of the published kinase inhibitor set; CERAPP: collaborative estrogen receptor activity prediction project; Does rational selection of training and test sets improve the outcome of QSAR modeling?; Materials cartography: representing and mining materials space using structural and electronic fingerprints; Trust, but verify II: a practical guide to chemogenomics data curation; Applicability domains for classification problems: benchmarking of distance to models for Ames mutagenicity set; Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen; Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches; Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS; Application of random forest approach to QSAR prediction of aquatic toxicity; Hierarchical QSAR technology based on the Simplex representation of molecular structure; Curation of chemogenomics data; Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives; Pred‐hERG: A novel web‐accessible computational tool for predicting cardiac toxicity; Progress towards a public chemogenomic set for protein kinases and a call for contributions
